Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT00136721 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Parkin Mutations and Their Functional Consequences

StatusCompleted
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor Publications: details revised at 16 of 16 entriesv10
  2. Notable Start date: Jun 2002 to Feb 8, 2005v9 Show 4 more changesShow less
    • Trial status: Active, Not Recruiting to Completed
    • Primary completion date: Feb 7, 2021
    • Study completion date: May 2006 to Feb 7, 2021
    • Publications: details revised at 16 of 16 entries
  3. Minor Re-verified, no change to tracked fieldsv8
  4. Minor Publications: 12 to 16v7
  5. Minor Trial status: Recruiting to Active, Not Recruiting
    • Site details revised
    • Publications: 11 to 12
    v6
Show 4 earlier versionsHide 4 earlier versions
  1. Minor Publications: 9 to 11v5
  2. Minor Publications: 8 to 9v4
  3. Minor Publications: 7 to 8v3
  4. Minor Eligibility criteria shortened, about 2 words
    • Study title expanded, about 4 words
    v2
  1. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Parkinson's disease (PD) is the most frequent neurodegenerative disease with a prevalence of 2% over 65 years and because of this high prevalence as the population ages, it is a major problem of public health. An exhaustive repertory of not only parkin mutations in autosomal recessive forms of PD but also in other known genes such as DJ-1, PINK1 and LRRK2, is of major importance for both genetic counseling in families affected with PD and physiopathological approaches to this disease. Through a French network for the study of Parkinson's disease genetics and extended collaborations with European, Mediterranean and other various countries, a total of 2934 subjects including 1683 patients and 1251 unaffected individuals has been collected since 2002. These samples consisted of 122 families with autosomal recessive PD, 285 cases of isolated early onset PD, 110 autosomal recessive and 129 autosomal dominant families with late onset PD, 201 isolated late onset PD cases and 250 matched controls. DNAs from all subjects are now available, lymphocytes and lymphoblastoid cell lines have been stored for most patients from France and recently, fresh fibroblasts have been obtained for some individuals. The genetic approach to autosomal recessive PD is focused on the identification of mutations in the parkin gene but also on the screening of DJ-1, PINK1 and LRRK2 genes.
Trial Details
NCT Number NCT00136721
Lead Sponsor Institut National de la Santé Et de la Recherche Médicale, France
Collaborators: National Institutes of Health (NIH)
Conditions
(from sponsor)
Parkinson's Disease
Related terms Parkinson Disease
Enrollment 2,500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov